A Study of Children With Refractory or Relapsed ALL

Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2005
The main purpose of this study is to find out which form of asparaginase (the native E. coli/Erwinia) or PEG-asparaginase) is more effective during induction treatment for children with acute lymphoblastic leukemia that has come back after treatment (relapsed) or is resistant to treatment (refractory)
Epistemonikos ID: 9fd349ba114a7f9ec4c61a3fa9d3f207b77cf137
First added on: Jan 21, 2022